Anbio Biotechnology Total Liabilities and Equity
Anbio Biotechnology (NNNN) had Total Liabilities and Equity of $30.24 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-04-07
- 2025-12-31: Liabilities and Equity $30.24M.
- 2024-12-31: Liabilities and Equity $18.92M.
- 2023-12-31: Liabilities and Equity $15.81M.
| Period end | Liabilities and Equity |
|---|---|
| 2025-12-31 | $30.24M 20-F · filed 2026-04-07 |
| 2024-12-31 | $18.92M 20-F · filed 2026-04-07 |
| 2023-12-31 | $15.81M 20-F · filed 2025-04-28 |